177 related articles for article (PubMed ID: 19135635)
1. [Erectile dysfunction and renal chronic insufficiency: etiology and management].
Phé V; Roupret M; Ferhi K; Barrou B; Cussenot O; Traxer O; Haab F; Beley S
Prog Urol; 2009 Jan; 19(1):1-7. PubMed ID: 19135635
[TBL] [Abstract][Full Text] [Related]
2. [Etiology and management of erectile dysfunction in patients with diabetes mellitus].
Phé V; Rouprêt M; Ferhi K; Traxer O; Haab F; Beley S
Prog Urol; 2009 Jun; 19(6):364-71. PubMed ID: 19467454
[TBL] [Abstract][Full Text] [Related]
3. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies.
Phé V; Rouprêt M
Diabetes Metab; 2012 Feb; 38(1):1-13. PubMed ID: 22056307
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
Axilrod AC
Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309
[TBL] [Abstract][Full Text] [Related]
5. [Erectile dysfunction after radical prostatectomy].
Becker AJ; Stief CG; Stadler TC
Aktuelle Urol; 2009 Sep; 40(5):289-93. PubMed ID: 19731191
[TBL] [Abstract][Full Text] [Related]
6. [Erectile dysfunction in renal failure patients and renal transplant recipients].
Kleinclauss F; Kleinclauss C; Bittard H
Prog Urol; 2005 Jun; 15(3):447-55; discussion 455-6. PubMed ID: 16097150
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and expectations of patients with erectile dysfunction: results of the SCORED study.
Claes H; Opsomer RJ; Andrianne R; Vanbelle S; Albert A; Vanderdonck F
Int J Impot Res; 2008; 20(4):418-24. PubMed ID: 18418390
[TBL] [Abstract][Full Text] [Related]
8. [New progress in etiological factor study and treatment of erectile dysfunction in chronic renal failure patients].
Wu JJ; Deng Y; Zhang SW
Zhonghua Nan Ke Xue; 2003; 9(4):296-8. PubMed ID: 12931376
[TBL] [Abstract][Full Text] [Related]
9. Penile prostheses in the management of impotence in patients with end-stage renal disease.
Ahuja SK; Krane NK; Hellstrom WJ
J La State Med Soc; 1998 Jan; 150(1):32-4. PubMed ID: 9448384
[TBL] [Abstract][Full Text] [Related]
10. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.
Kapur V; Chien CV; Fuess JE; Schwarz ER
Rev Cardiovasc Med; 2008; 9(3):187-95. PubMed ID: 18953278
[TBL] [Abstract][Full Text] [Related]
11. Sexual dysfunction in chronic renal failure.
Bellinghieri G; Santoro D; Mallamace A; Savica V
J Nephrol; 2008; 21 Suppl 13():S113-7. PubMed ID: 18446743
[TBL] [Abstract][Full Text] [Related]
12. Current management of erectile dysfunction after cancer treatment.
Peltier A; van Velthoven R; Roumeguère T
Curr Opin Oncol; 2009 Jul; 21(4):303-9. PubMed ID: 19509501
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological therapy for the treatment of sexual dysfunction--are we there yet?
Costabile RA
J Urol; 2008 Mar; 179(3):819-20. PubMed ID: 18221964
[No Abstract] [Full Text] [Related]
14. Therapy Insight: sexual dysfunction in patients with chronic kidney disease.
Finkelstein FO; Shirani S; Wuerth D; Finkelstein SH
Nat Clin Pract Nephrol; 2007 Apr; 3(4):200-7. PubMed ID: 17389889
[TBL] [Abstract][Full Text] [Related]
15. [Erectile dysfunction and quality of life in patients with chronic renal failure].
Bellinghieri G; Santoro D; Satta E; Savica V
G Ital Nefrol; 2008; 25(6):713-7. PubMed ID: 19048573
[TBL] [Abstract][Full Text] [Related]
16. A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients.
Schwarz ER; Rastogi S; Rodriguez JJ; Kapur V; Sulemanjee N; Gupta R; Rosanio S
Int J Impot Res; 2005 Dec; 17 Suppl 1():S37-43. PubMed ID: 16391541
[TBL] [Abstract][Full Text] [Related]
17. PDE5 inhibitors: is there more to come besides erectile dysfunction?
Stief C
Eur Urol; 2007 Oct; 52(4):943-4. PubMed ID: 17683851
[No Abstract] [Full Text] [Related]
18. Is penile length a factor in treatment of erectile dysfunction with PDE-5 inhibitor?
Savas M; Yeni E; Ciftci H; Topal U; Utangac M; Verit A
J Androl; 2009; 30(5):515-9. PubMed ID: 19234311
[TBL] [Abstract][Full Text] [Related]
19. [Tadalafil for erectile dysfunction: outstanding efficacy for 36 hours].
Deng SM
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):857-60. PubMed ID: 18998474
[TBL] [Abstract][Full Text] [Related]
20. [Type V phosphodiesterase inhibitor erection-provoking test with audio-visual sexual stimulation for the diagnosis of erectile dysfunction].
Zhu XW; Guo JP; Zhang FB; Zhong DC; Fang JJ; Li FY
Zhonghua Nan Ke Xue; 2008 May; 14(5):445-7. PubMed ID: 18572866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
